Arbutus Biopharma Corp (ABUS)
2.75
+0.11
(+4.17%)
USD |
NASDAQ |
Apr 23, 16:00
2.745
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Price to Book Value: 4.674 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 4.674 |
| April 22, 2024 | 4.487 |
| April 19, 2024 | 4.623 |
| April 18, 2024 | 4.640 |
| April 17, 2024 | 4.724 |
| April 16, 2024 | 4.962 |
| April 15, 2024 | 5.047 |
| April 12, 2024 | 4.946 |
| April 11, 2024 | 5.149 |
| April 10, 2024 | 5.064 |
| April 09, 2024 | 5.107 |
| April 08, 2024 | 5.251 |
| April 05, 2024 | 5.302 |
| April 04, 2024 | 5.098 |
| April 03, 2024 | 4.962 |
| April 02, 2024 | 4.283 |
| April 01, 2024 | 4.351 |
| March 28, 2024 | 4.385 |
| March 27, 2024 | 4.419 |
| March 26, 2024 | 4.232 |
| March 25, 2024 | 4.232 |
| March 22, 2024 | 4.233 |
| March 21, 2024 | 4.317 |
| March 20, 2024 | 4.317 |
| March 19, 2024 | 4.233 |
| Date | Value |
|---|---|
| March 18, 2024 | 4.300 |
| March 15, 2024 | 4.436 |
| March 14, 2024 | 4.419 |
| March 13, 2024 | 4.571 |
| March 12, 2024 | 4.554 |
| March 11, 2024 | 4.605 |
| March 08, 2024 | 4.622 |
| March 07, 2024 | 4.571 |
| March 06, 2024 | 4.639 |
| March 05, 2024 | 4.520 |
| March 04, 2024 | 4.588 |
| March 01, 2024 | 4.724 |
| February 29, 2024 | 4.486 |
| February 28, 2024 | 4.614 |
| February 27, 2024 | 4.679 |
| February 26, 2024 | 4.679 |
| February 23, 2024 | 4.679 |
| February 22, 2024 | 4.662 |
| February 21, 2024 | 4.614 |
| February 20, 2024 | 4.614 |
| February 16, 2024 | 4.646 |
| February 15, 2024 | 4.662 |
| February 14, 2024 | 4.662 |
| February 13, 2024 | 4.630 |
| February 12, 2024 | 4.598 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.618
Minimum
Jun 14 2019
5.302
Maximum
Apr 05 2024
2.884
Average
2.689
Median
Jul 21 2023
Price to Book Value Benchmarks
| Moderna Inc | 2.982 |
| Pacira BioSciences Inc | 1.433 |
| Chimerix Inc | 0.4284 |
| Karyopharm Therapeutics Inc | -- |
| Corvus Pharmaceuticals Inc | 1.940 |
Price to Book Value Related Metrics
| PS Ratio | 25.16 |
| Price | 2.75 |
| Earnings Yield | -16.00% |
| Market Cap | 495.48M |